Aytekin Oto to Carcinoma, Transitional Cell
This is a "connection" page, showing publications Aytekin Oto has written about Carcinoma, Transitional Cell.
Connection Strength
0.335
-
ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer: 2021 Update. J Am Coll Radiol. 2021 May; 18(5S):S126-S138.
Score: 0.176
-
ACR Appropriateness Criteria® Post-Treatment Surveillance of Bladder Cancer. J Am Coll Radiol. 2019 Nov; 16(11S):S417-S427.
Score: 0.159